CYABRA, INC. (CYAB) Form S-1/A — Sep 15, 2026
Cyabra Inc. filed an S-1/A on September 15, 2026 to register the resale of up to 21,645,176 shares of common stock by selling shareholders, equal to approximately 123% of the 17,597,071 shares outstanding as of August 31, 2026. The shares stem from a July 2026 PIPE that grossed roughly $6 million at $0.435 per share and from the conversion of Series A and Series B preferred stock at a reduced $0.435 conversion price. The company receives no proceeds from the resales; its only potential inflow is up to approximately $1,117,222 if outstanding pre-funded warrants and warrants are exercised for cash.
Key figures
- Gross Proceeds
- $0 to the company from shareholder resales; up to approximately $1,117,222 from full cash exercise of Pre-Funded Warrants and Warrants
- Offering Price
- $0.435 per share and $0.4349 per Pre-Funded Warrant (July 2026 PIPE purchase price; resales themselves occur at prevailing market prices)
- Shares Offered
- 21645176
- Shares Outstanding
- 17,597,071 prior to offering (as of August 31, 2026); 39,242,247 after this offering assuming full exercise for cash of Pre-Funded Warrants and Warrants
- Iia grants
- approximately $719 thousand received; theoretical repayment obligation approximately $527 thousand as of December 15, 2025; 3% royalty rate
- Insider ownership
- approximately 20% held by executive officers, directors and affiliates
- Nasdaq minimum bid
- $1.00 (cure by December 7, 2026)
- Accumulated deficit
- approximately $61.6 million as of June 30, 2026
- Nasdaq mvls minimum
- $50 million (deficient since March 27, 2026; cure by November 9, 2026)
- Pipe gross proceeds
- $6 million (PIPE closed July 10, 2026)
- Nasdaq mvphs minimum
- $15,000,000 (cure by December 7, 2026)
- Warrant exercise prices
- Series A $0.50 (5-year term), Series B $0.45 (12-month term), Pre-Funded $0.0001
- Last reported sale price
- $0.3025 (September 14, 2026)
- Series a warrants issued
- 13818770
- Series b warrants issued
- 13818770
- Preferred conversion price
- $0.435 per share
- Conversion closing issuance
- 9,756,323 shares plus a Pre-Funded Warrant for 25,006,895 shares (closed September 9, 2026)
- Alpha exchange preferred value
- $10,660,000
- Pipe prefunded warrants issued
- 12643680
- Alpha exchange closing issuance
- 24,505,747 Pre-Funded Warrants plus Series A and Series B Warrants for 24,505,747 shares each (closed September 9, 2026)
- Fy2024 total comprehensive loss
- $15.6 million
- Fy2025 total comprehensive loss
- $12.8 million
- Registered shares pct of outstanding
- approximately 123%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.